Search

everythinglearnresearchcommunity

for

Search:↓

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Skin cancer often starts from Lgr5+ progenitor cells.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Seborrheic keratosis is a common, harmless skin growth that can look like cancer, so it may need a biopsy.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Hedgehog pathway inhibitors could be effective in treating melanoma.

HPV8 causes skin cancer by expanding specific skin stem cells.

Increasing SSAT makes skin more prone to cancer.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

A mutation in the KRT82 gene is significantly associated with Alopecia Areata.

Hair follicles protect melanocytes from sun damage, helping them replenish skin.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Skin aging and cancer development are influenced by the competition between stem cells.

Smad2 and Smad3 are essential for normal skin development, and their absence causes severe skin issues and cancer.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

GLI2 activates GLI1, promoting skin tumor growth and hair development.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Cholesteatoma shows abnormal and increased EGF receptor expression, indicating its rapid growth.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Melanocyte stem cells can become melanoma, resembling human melanoma.